Keyphrases
Seliciclib
100%
Systems Biology Approach
100%
Drug Performance
100%
Anticancer Agents
33%
Therapeutic Effect
16%
Mathematical Modeling
16%
Cell Division
16%
Cell Growth
16%
Development Testing
16%
Drug Development
16%
Mode of Action
16%
Kinase Inhibitor
16%
R-roscovitine
16%
Molecular Pathways
16%
Clinical Trial Results
16%
In Vitro Experiment
16%
Animal Model Study
16%
Clinical Testing
16%
Oncology Applications
16%
Non-oncology
16%
Biochemistry, Genetics and Molecular Biology
Cyclin-Dependent Kinase
100%
Cell Division
50%
Anticancer
50%
Cell Growth
50%
Phosphotransferase
50%
Kinase
50%
Animal Model
50%
Clinical Trial Results
50%
Medicine and Dentistry
Seliciclib
100%
Anticarcinogen
28%
In Vitro
28%
Cyclin-Dependent Kinase
28%
Cell Division
14%
Cell Growth
14%
Clinical Trial Results
14%
Oncology
14%
Phosphotransferase Inhibitor
14%
Therapy Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Roscovitine
100%
Anticarcinogen
28%
Drug Development
14%
Phosphotransferase Inhibitor
14%
Therapeutic Effect
14%
Clinical Trial Results
14%